Current Perspectives on Left Ventricular Geometry in Systemic Hypertension

被引:44
作者
Oktay, Ahmet Afsin [1 ]
Lavie, Carl J. [1 ]
Milani, Richard V. [1 ]
Ventura, Hector O. [1 ]
Gilliland, Yvonne E. [1 ]
Shah, Sangeeta [1 ]
Cash, Michael E. [1 ]
机构
[1] Univ Queensland, Sch Med, John Ochsner Heart & Vasc Inst, Dept Cardiovasc Dis,Ochsner Clin Sch, New Orleans, LA USA
关键词
Hypertension; Left ventricular geometry; Left ventricular hypertrophy; Remodeling; Anti-hypertension therapy; END-POINT REDUCTION; TARGET ORGAN DAMAGE; ANTIHYPERTENSIVE TREATMENT; LOSARTAN INTERVENTION; DIABETES-MELLITUS; HEART-FAILURE; CARDIAC STRUCTURE; BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; 4-TIERED CLASSIFICATION;
D O I
10.1016/j.pcad.2016.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension (HTN) is a global health problem and a leading risk factor for cardiovascular disease (CVD) morbidity and mortality. The hemodynamic overload from HTN causes left ventricular (LV) remodeling, which usually manifests as distinct alterations in LV geometry, such as concentric remodeling or concentric and eccentric LV hypertrophy (LVH). In addition to being a common target organ response to HTN, LV geometric abnormalities are well-known independent risk factors for CVD. Because of their prognostic implications and quantifiable nature, changes in LV geometric parameters have commonly been included as an outcome in anti-HTN drug trials. The purpose of this paper is to review the relationship between HTN and LV geometric changes with a focus on (1) diagnostic approach, (2) epidemiology, (3) pathophysiology, (4) prognostic effect and (5) LV response to anti-HTN therapy and its impact on CVD risk reduction. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 98 条
[1]  
[Anonymous], HEART
[2]  
[Anonymous], 2013, J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2013.05.019
[3]   LV Mass Assessed by Echocardiography and CMR, Cardiovascular Outcomes, and Medical Practice [J].
Armstrong, Anderson C. ;
Gidding, Samuel ;
Gjesdal, Ola ;
Wu, Colin ;
Bluemke, David A. ;
Lima, Joao A. C. .
JACC-CARDIOVASCULAR IMAGING, 2012, 5 (08) :837-848
[4]  
Aro AL, 2016, EUROPACE
[5]   Clinical Impact of Left Ventricular Hypertrophy and Implications for Regression [J].
Artham, Surya M. ;
Lavie, Carl J. ;
Milani, Richard V. ;
Patel, Dharmendrakumar A. ;
Verma, Anil ;
Ventura, Hector O. .
PROGRESS IN CARDIOVASCULAR DISEASES, 2009, 52 (02) :153-167
[6]   Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes [J].
Baggish, Aaron L. ;
Wang, Francis ;
Weiner, Rory B. ;
Elinoff, Jason M. ;
Tournoux, Francois ;
Boland, Arthur ;
Picard, Michael H. ;
Hutter, Adolph M., Jr. ;
Wood, Malissa J. .
JOURNAL OF APPLIED PHYSIOLOGY, 2008, 104 (04) :1121-1128
[7]   Four-Group Classification of Left Ventricular Hypertrophy Based on Ventricular Concentricity and Dilatation Identifies a Low-Risk Subset of Eccentric Hypertrophy in Hypertensive Patients [J].
Bang, Casper N. ;
Gerdts, Eva ;
Aurigemma, Gerard P. ;
Boman, Kurt ;
de Simone, Giovanni ;
Dahlof, Bjorn ;
Kober, Lars ;
Wachtell, Kristian ;
Devereux, Richard B. .
CIRCULATION-CARDIOVASCULAR IMAGING, 2014, 7 (03) :422-U20
[8]   Long-Term Antihypertensive Treatment Fails to Improve E/e′ Despite Regression of Left Ventricular Mass An Anglo-Scandinavian Cardiac Outcomes Trial Substudy [J].
Barron, Anthony J. ;
Hughes, Alun D. ;
Sharp, Andrew ;
Baksi, Arun J. ;
Surendran, Praveen ;
Jabbour, Richard J. ;
Stanton, Alice ;
Poulter, Neil ;
Fitzgerald, Des ;
Sever, Peter ;
O'Brien, Eoin ;
Thom, Simon ;
Mayet, Jamil .
HYPERTENSION, 2014, 63 (02) :252-+
[9]   ECM remodeling in hypertensive heart disease [J].
Berk, Bradford C. ;
Fujiwara, Keigi ;
Lehoux, Stephanie .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :568-575
[10]   Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis [J].
Bliziotis, Ioannis A. ;
Destounis, Antonis ;
Stergiou, George S. .
JOURNAL OF HYPERTENSION, 2012, 30 (07) :1289-1299